Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:57:14 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



V:NGEN - Nervgen Pharma Corp. - http://www.nervgen.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NGEN - V  0.31.93·1.980.41.93-0.17-8.1167.43212542.08  2.08  1.933.98  1.55May 16May 1615 min RT 2¢
TSX-V - V0.31.93·1.980.41.93-0.17-8.1131.42521692.08  2.08  1.933.98  1.55May 1615 min
NEO ATS - U 1.96-0.14-6.715.930282.02  2.04  1.95May 1615 min
Alpha - A 1.95-0.15-7.13.8762.00  2.00  1.95May 1615 min
Pure - P 2.100.021    Apr 2615 min
Chi-X - X 1.96-0.14-6.74.48172.03  2.03  1.95May 1615 min
CX2 - H 2.04-0.06-2.97.315182.00  2.04  2.00May 1615 min
CXD - D 2.100.26    May 0815 min
TriAct - M 2.104.599    Sep 04-2015 min

Recent Trades - Last 10 of 254
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-16 13:42C:NGEN2.10News ReleaseNervgen Pharma's March 31 cash at $30.3-million
2024-05-16 08:04C:NGEN2.10SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-16 08:04C:NGEN2.10SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-07 12:01C:NGEN2.10News ReleaseNervgen files mgmt info circular for June 4 AGM
2024-05-02 07:54C:NGEN2.16In the NewsGlobe says new coverage rates Nervgen Pharma "buy"
2024-04-25 12:29C:NGEN2.09News ReleaseNervgen Pharma hires Russo Partners for PR
2024-04-18 00:17C:NGEN1.98SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-18 00:17C:NGEN1.98SEDAR MD & ASEDAR MD & A
2024-04-17 14:20C:NGEN2.02News ReleaseNervgen Pharma's Dec. 31 cash at $11.7-million
2024-04-03 20:43C:NGEN2.34Prospectus ApprovedNervgen Pharma prospectus offering
2024-03-28 13:21C:NGEN2.18News ReleaseNervgen Pharma closes $23.01-million bought deal
2024-03-22 07:38C:NGEN2.49Resume TradingNervgen Pharma resuming at the open
2024-03-21 16:12C:NGEN2.49News ReleaseNervgen Pharma arranges $20-million offering
2024-03-21 15:51C:NGEN2.55Halt TradingNervgen Pharma halted at 12:43 p.m. PT
2024-02-20 17:47C:NGEN3.32News ReleaseNervgen grants options to buy shares
2024-02-15 13:06C:NGEN3.01News ReleaseNervgen to complete NVG-291 enrolment in Q2 2024
2023-11-09 14:25C:NGEN1.96News ReleaseNervgen Pharma's Sept. 30 cash at $14.8-million
2023-11-09 10:12C:NGEN1.96SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-09 10:12C:NGEN1.96SEDAR Interim MD & ASEDAR Interim MD & A
2023-10-23 11:30C:NGEN1.79News ReleaseNervgen receives fast-track designation for NVG-291